Ocular Surgery News U.S. Edition Current Issue
The following articles appeared in the print edition of Ocular Surgery News U.S. Edition.
Table of Contents
- Practitioners, researchers continue to probe the use of anti-VEGF therapy for ROP
-
- Cataract surgeons should become more familiar with vitrectomy procedures
- Deadline for meeting stage 2 meaningful use criteria for EHRs extended to 2014
- Homonymous hemianopia and vision loss progress after gunshot wound, decompressive craniectomy Greg D. Rice, MS-III; David W. Silverstein, MD, FACS; Steven M. Silverstein, MD, FACS
- How soon after discharge do you see an infant who had stage 1 or 2 ROP but reached near complete vascularization and was improving as expected without treatment?
- Investigational topical IL-1 blockade intended to treat dry eye
- Microincision, small-incision coaxial phaco similarly safe, effective for hard cataracts
- New technology enables earlier glaucoma detection Sanjay Asrani, MD
- Prostaglandin analogue showing promise in clinical practice
-
- Scleral buckling should not be abandoned, surgeon says
- Wavefront-guided, wavefront-optimized platforms for LASIK and PRK yield comparable results Majid Moshirfar, MD; Erik Anderson; Maylon Hsu
- Femtosecond laser-assisted cataract surgery promising but still evolving Uday Devgan, MD
- All ophthalmologists should be familiar with ROP and its treatments Richard L. Lindstrom, MD
- Woman has decreased vision, pain and photophobia in left eye Kevin Sitko, MD; Jay S. Duker, MD
- Diabetic vitrectomy patients on anticoagulation agents may have no increased risk of hemorrhage
- Re-bubbling may facilitate graft adhesion after DSEK
- Standard weakening procedures may not harm macula
-
- Superior limbic keratoconjunctivitis can be treated with liquid nitrogen cryotherapy Frederick W. Fraunfelder, MD